Endovasc gets patent notice protecting its muscle-mass technology

By Elaine Rigoli

Tampa, Fla., July 6 - Endovasc, Inc. has received a patent issue notification from the U.S. Patent and Trademark Office for the patent application entitled "Development of Muscle Mass in a Mammal." Issuance of the patent is expected within the next few weeks.

"We are extremely pleased to receive this patent issue notification regarding the protection of our muscle-mass technology. The issue notification means this technology is now protected in the United States. The company has also filed for patent protection in Europe, Asia and other regions of the world. We expect patents to be granted upon completion of the patent application examination process," chairman and chief executive officer Diane Dottavio said in a news release.

Endovasc, located in Montgomery, Texas, is focused on developing and commercializing drug candidates in the areas of cardiovascular and metabolic medicine.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.